CCNB2 has been shown to be highly expressed in a range of human cancers, such as lung cancer, bladder cancer, nasopharyngeal cancer, and liver cancer (Stav et al. 2007; Lei et al. 2016; Gao et al. 2018; Qian et al. 2020). This evidence concerns the gene CCNB2 and urinary bladder cancer.